Name Card
rp01670 picture

Dr Ng, Kwong Man 吳廣文

Title:
Scientific Officer

Contact Information
rp01670 picture
Office:

Dr Ng, Kwong Man 吳廣文

Title:
Scientific Officer

Short Biography:

Current research interests:

- Treatment of genetic diseases with synthetic chemically modified RNAs

- Comercialization of trophoblastic stem cell derived exosomes

- Development of novel target-specific drug delivery systems

Professional Qualifications
YearAwarding InstitutionQualification
2006The University of Hong KongPh.D
Biography

Dr. Kwong-Man Ng obtained his Ph.D degree in the Department of Zoology (now as part of the school of biological science), The University of Hong Kong in 2006. He has been working as visiting scholar in the University of Western Ontario and the University of British Columbia and received post-doctoral training on Human Stem Cell biology in the University of California, Davis, and the Departments of Physiology and Medicine, the University of Hong Kong. Currently, he is working as a Research Assistant Professor at the cardiology division, the Department of Medicine, The University of Hong Kong. His research focuses on the biotechnological and clinical applications of human pluripotent stem cells in the studies of inherited cardiac disorders. Owing to the lack of human cardiomyocyte-based cellular models, the study of the pathogenic mechanism associated with particular gene mutation have been a challenging task. To date, with the advancement in the induced pluripotent stem cells (iPSCs) technology, terminally differentiated somatic cells from patients carrying specific cardiomyopathy-associated mutations can be reprogrammed into iPSCs and subsequently differentiated into functional cardiomyocytes. This offers a new approach for modeling human inherited cardiac disorders (Figure 1). In recent years, Dr. Ng and colleagues in the cardiology division has generated various iPSCs lines from the patients suffered from different types of cardiomyopathies, these studies not only provided new insights on the pathogenic mechanisms underlining the mutations of DES and LMNA, but also offered a new human-cardiomyocytes based platform for drug testing.

 
Professional Societies
Term PeriodPositionProfessional Societies
05/2016Editorial board member, Cardiology sectionScientific Reports
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!